COI Centro Oncologico Internacional S.A.P.I. de C.V.

Mexico City 04700

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer

Studies at this site

• A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. — Recruiting now
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling